메뉴 건너뛰기




Volumn 13, Issue 19, 2005, Pages 5613-5622

Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8- nitroquinazolines as EGFR signaling-targeted inhibitors

Author keywords

Breast cancer; Cellular signaling; EGFR inhibitor; ErbB 2; Quinazolines

Indexed keywords

5 (4 METHOXY)ANILINO 4 HYDROXY 8 NITROQUINAZOLINE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 23944442253     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.05.045     Document Type: Article
Times cited : (52)

References (21)
  • 12
    • 33645417102 scopus 로고    scopus 로고
    • US Patent US2004023957-A1, 2004.
    • Wang, S.; Yang, D.; Enyedy, I. US Patent US2004023957-A1, 2004.
    • Wang, S.1    Yang, D.2    Enyedy, I.3
  • 17
    • 0003797555 scopus 로고    scopus 로고
    • Tripos Associates: St. Louis, MO
    • Sybyl, Version 6.8; Tripos Associates: St. Louis, MO, 2000.
    • (2000) Sybyl, Version 6.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.